Seven Grand Managers’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34K Hold
2,500
– – ﹤0.01% 153
2026
Q2
$38.8K Buy
+2,500
New +$27.6K ﹤0.01% 175

Other funds holding MTRI

Seven Grand Managers's MTRI Position: Q3 2026 in Review

Seven Grand Managers held its Mentari Therapeutics, Inc. Common Stock (MTRI) position steady in Q3 2026 at 2,500 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #153.

Seven Grand Managers first reported a position in MTRI in Q2 2026 and has held it in 2 quarters since. The position peaked at $38.8K in Q2 2026. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.

  • Seven Grand Managers held 2,500 shares of Mentari Therapeutics, Inc. Common Stock worth $34K as of Q3 2026.
  • Seven Grand Managers left its Mentari Therapeutics, Inc. Common Stock share count unchanged in Q3 2026.
  • Mentari Therapeutics, Inc. Common Stock made up ﹤0.01% of Seven Grand Managers's portfolio in Q3 2026, its #153 holding.
  • Seven Grand Managers first reported a position in Mentari Therapeutics, Inc. Common Stock in Q2 2026 and has held it in 2 quarters since.
  • Seven Grand Managers's Mentari Therapeutics, Inc. Common Stock position peaked at $38.8K in Q2 2026.
  • 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.

Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.